- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 3 Spinal Muscular Atrophy in Australia
Total 424 results
-
Cooperative International Neuromuscular Research...United States Department of Defense; National Institutes of Health (NIH); U.S... and other collaboratorsUnknownDuchenne Muscular DystrophyUnited States, Canada, Australia, India, Israel, Argentina, Italy, Sweden
-
Clarity Pharmaceuticals LtdCompleted
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
-
Endo PharmaceuticalsCompletedAdvanced Dupuytren's DiseaseAustralia
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, France, Spain, Australia, Poland
-
Bayside HealthTerminated
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.CompletedDuchenne Muscular DystrophyKorea, Republic of, Chile, Taiwan, China, United States, United Kingdom, Netherlands, Spain, Australia, Norway, Russian Federation, Greece, Italy, Turkey, Mexico, Canada, Hong Kong, New Zealand, Ukraine
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Australia, Canada, United Kingdom, Japan, Bulgaria, Italy, Poland
-
BioMarin PharmaceuticalNo longer availableDuchenne Muscular DystrophyUnited States, Germany, United Kingdom, Japan, Netherlands, France, Spain, Korea, Republic of, Italy, Belgium, Taiwan, Argentina, Australia, Bulgaria, Czechia, Israel, Norway, Poland, Russian Federation, Turkey
-
AMO Pharma LimitedRecruitingCongenital Myotonic DystrophyUnited States, Canada, Australia, New Zealand
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
GlaxoSmithKlineWithdrawn
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
Peter MacCallum Cancer Centre, AustraliaJanssen, LPRecruiting
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompleted
-
AMO Pharma LimitedCompletedCongenital Myotonic DystrophyUnited States, Canada, New Zealand, Australia, United Kingdom
-
Catabasis PharmaceuticalsCompletedMuscular Dystrophy, DuchenneUnited States, Canada, Australia, United Kingdom, Germany, Ireland, Israel, Sweden
-
Cancer Trials AustraliaHuman Genome Sciences Inc.UnknownSymptomatic Waldenstroms MacroglobulinaemiaAustralia
-
Santhera PharmaceuticalsCompletedMuscular Dystrophy, Duchenne | Ambulatory CareUnited States, Spain, Austria, Belgium, France, Germany, Italy, Netherlands, Sweden, Switzerland
-
Hoffmann-La RocheCompletedDuchenne Muscular DystrophyUnited States, Belgium, Canada, Australia, Japan, France, Netherlands, Spain, Argentina, Germany, Italy, United Kingdom, Sweden
-
Gilead SciencesTerminated
-
Santhera PharmaceuticalsTerminatedDuchenne Muscular DystrophyUnited States, Belgium, United Kingdom, Austria, France, Germany, Italy, Spain, Switzerland
-
AstraZenecaTakedaCompleted
-
Peter MacCallum Cancer Centre, AustraliaJanssen-Cilag Ltd.CompletedMultiple MyelomaAustralia
-
PTC TherapeuticsCompletedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, Germany, Spain, Sweden, Canada, Italy, Australia, Belgium, France, Israel, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, Belgium, Australia, Canada, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Novartis PharmaceuticalsCompletedBone NeoplasmsAustralia
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, Duchenne | Musculoskeletal DiseaseUnited States, Taiwan, India, Korea, Republic of, Thailand, Australia, Brazil, Bulgaria, Canada, China, Hong Kong, Malaysia, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Japan
-
Paracelsus Medical UniversityCompletedCoronary Artery Disease | Type 2 Diabetes MellitusAustria
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingAging | Dementia, Vascular | Cognitive Decline | Dementia, Mixed | Neuro-Degenerative Disease | Dementia of Alzheimer Type | White Matter HyperintensityAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedMultiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With LymphomaAustralia
-
PTC TherapeuticsCooperative International Neuromuscular Research Group; The John Walton Muscular...Active, not recruitingMuscular Dystrophy, DuchenneGermany, France, United Kingdom, Brazil, Italy, Austria, Sweden, Czechia, Greece, Hungary, Israel, Latvia, Norway, Portugal, Romania, Slovenia
-
Sarepta Therapeutics, Inc.Active, not recruitingDuchenne Muscular DystrophyUnited States, Korea, Republic of, Italy, United Kingdom, Canada, Poland, Spain, France, Germany, Belgium, Australia, Czechia, Serbia, Greece, Argentina, Bulgaria, Denmark, Hungary, India, Ireland, Israel, Mexico, Russian Federation, ...
-
Walter and Eliza Hall Institute of Medical ResearchMelbourne Health; Royal Marsden NHS Foundation TrustCompleted
-
GlaxoSmithKlineTerminatedMuscular DystrophiesFrance, Bulgaria, Denmark, Germany, Belgium, Canada, Spain, Turkey, United Kingdom, Korea, Republic of, Brazil, Netherlands, Italy, Japan, Czech Republic, Chile, Israel, Hungary, Russian Federation, Australia, Poland, Norway, Argentina and more
-
Santhera PharmaceuticalsTerminatedDuchenne Muscular Dystrophy (DMD)United States, Spain, Netherlands, Sweden, Germany, France, Belgium, United Kingdom, Italy, Ireland, Switzerland, Austria, Bulgaria, Hungary, Israel
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompletedMultiple Myeloma | Cutaneous LymphomaAustralia
-
Medical University of ViennaMedical Scientific Fund of the Mayor of ViennaRecruitingCerebral Arteriovenous MalformationAustria
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
Chelsea TherapeuticsCompletedMultiple System Atrophy | Neurogenic Orthostatic Hypotension | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Autonomic NeuropathyUnited States, Australia, Canada, New Zealand
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Stage 4S Neuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Musculoskeletal Diseases | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, DuchenneUnited States, Spain, Korea, Republic of, Belgium, France, Canada, Australia, United Kingdom, Israel, Italy, Brazil, Chile, Czechia, Sweden, Switzerland, Turkey, Germany, Poland